JP2008519767A5 - - Google Patents

Download PDF

Info

Publication number
JP2008519767A5
JP2008519767A5 JP2007540194A JP2007540194A JP2008519767A5 JP 2008519767 A5 JP2008519767 A5 JP 2008519767A5 JP 2007540194 A JP2007540194 A JP 2007540194A JP 2007540194 A JP2007540194 A JP 2007540194A JP 2008519767 A5 JP2008519767 A5 JP 2008519767A5
Authority
JP
Japan
Prior art keywords
formulation
chemotherapeutic
herbal
paeonia
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007540194A
Other languages
English (en)
Japanese (ja)
Other versions
JP5057987B2 (ja
JP2008519767A (ja
Filing date
Publication date
Priority claimed from US11/100,433 external-priority patent/US7534455B2/en
Application filed filed Critical
Publication of JP2008519767A publication Critical patent/JP2008519767A/ja
Publication of JP2008519767A5 publication Critical patent/JP2008519767A5/ja
Application granted granted Critical
Publication of JP5057987B2 publication Critical patent/JP5057987B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2007540194A 2004-11-09 2005-11-09 薬草組成物phy906及びその化学療法における使用 Expired - Lifetime JP5057987B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US62594304P 2004-11-09 2004-11-09
US60/625,943 2004-11-09
US11/100,433 2005-04-07
US11/100,433 US7534455B2 (en) 2000-03-09 2005-04-07 Herbal composition PHY906 and its use in chemotherapy
PCT/US2005/040605 WO2006053049A2 (en) 2004-11-09 2005-11-09 Herbal composition phy906 and its use in chemotherapy

Publications (3)

Publication Number Publication Date
JP2008519767A JP2008519767A (ja) 2008-06-12
JP2008519767A5 true JP2008519767A5 (cg-RX-API-DMAC7.html) 2010-07-22
JP5057987B2 JP5057987B2 (ja) 2012-10-24

Family

ID=36337179

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007540194A Expired - Lifetime JP5057987B2 (ja) 2004-11-09 2005-11-09 薬草組成物phy906及びその化学療法における使用

Country Status (8)

Country Link
US (1) US7534455B2 (cg-RX-API-DMAC7.html)
EP (1) EP1812028A4 (cg-RX-API-DMAC7.html)
JP (1) JP5057987B2 (cg-RX-API-DMAC7.html)
CN (2) CN101098705A (cg-RX-API-DMAC7.html)
AU (1) AU2005304493B2 (cg-RX-API-DMAC7.html)
CA (1) CA2583761C (cg-RX-API-DMAC7.html)
TW (1) TW200630105A (cg-RX-API-DMAC7.html)
WO (1) WO2006053049A2 (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8871279B2 (en) 2000-03-09 2014-10-28 Yale University Use of the combination of PHY906 and a tyrosine kinase inhibitor as a cancer treatment regimen
US8394365B2 (en) * 2003-09-17 2013-03-12 Nektar Therapeutics Multi-arm polymer prodrugs
CN101730535A (zh) 2007-02-15 2010-06-09 耶鲁大学 草药组合物phy906及其在化疗中的用途
TWI361075B (en) * 2007-03-16 2012-04-01 Brion Res Inst Of Taiwan Pharmaceutical composition for inhibiting the syndrome of snore
US20110111070A1 (en) 2007-10-25 2011-05-12 Yung-Chi Cheng Use of phy906 as treatment for inflammatory bowel disease and/or irritable bowel syndrome
WO2011150175A2 (en) * 2010-05-26 2011-12-01 President And Fellows Of Harvard College Compositions and methods for pain reduction
US8541382B2 (en) 2010-11-13 2013-09-24 Sirbal Ltd. Cardiac glycoside analogs in combination with emodin for cancer therapy
US8734859B1 (en) 2010-11-13 2014-05-27 Sirbal Ltd. Molecular combinations for cancer or other disease treatment
US9066974B1 (en) 2010-11-13 2015-06-30 Sirbal Ltd. Molecular and herbal combinations for treating psoriasis
US9095606B1 (en) 2010-11-13 2015-08-04 Sirbal Ltd. Molecular and herbal combinations for treating psoriasis
US20170049835A1 (en) 2015-07-29 2017-02-23 Sirbal Ltd. Herbal Combinations For Treating Scalp Conditions
EP3498288A1 (en) 2013-12-02 2019-06-19 Sirbal Ltd. Herbal combinations for treatment of a skin condition
CN109414422A (zh) * 2016-05-23 2019-03-01 耶鲁大学 使用包含phy906提取物、黄芩提取物或来自这些提取物的化合物的联合疗法改善抗免疫检查点抑制剂的治疗指数
AU2017281065B2 (en) * 2016-06-22 2022-10-27 Yale University Mechanism based quality control for botanical medicine
US10086026B2 (en) 2016-06-27 2018-10-02 Uwais M. Syed Combined herbal and pharmaceutical composition and method
CN107970299A (zh) * 2017-11-16 2018-05-01 饶本强 一种清热解毒抗肿瘤复方制剂
JP7132344B2 (ja) 2018-02-28 2022-09-06 チュンアン・ユニヴァーシティ・インダストリー・アカデミック・コーペレーション・ファウンデーション 悪液質および筋損失の予防、改善または治療用組成物
CN110105149B (zh) * 2019-04-23 2022-02-01 来宾市农业科学院 一种蚕沙防治甘蔗螟虫的方法
CN109991341B (zh) * 2019-05-17 2022-04-01 无限极(中国)有限公司 一种制首乌的质量检测方法
JP2023504202A (ja) * 2019-12-09 2023-02-01 イエール ユニバーシティ がんの再発を予防するための組成物および方法
US20240226214A1 (en) * 2020-03-30 2024-07-11 Yale University Methods for treating inflammatory and fibrotic diseases and disorders
US12011284B2 (en) * 2020-05-19 2024-06-18 Peachy Corp. Systems and methods for preventing and treating wrinkles

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5936621A (ja) * 1982-08-25 1984-02-28 Tsumura Juntendo Inc 脂肪分解促進作用阻害剤
US5595756A (en) * 1993-12-22 1997-01-21 Inex Pharmaceuticals Corporation Liposomal compositions for enhanced retention of bioactive agents
US5665393A (en) * 1996-09-03 1997-09-09 International Medical Research, Inc. Herbal composition for treating prostate carcinoma
US6048847A (en) * 1997-09-30 2000-04-11 Dabur Research Foundation Use of betulinic acid and its derivatives for inhibiting cancer growth and a method of monitoring this
US6630176B2 (en) * 2000-03-07 2003-10-07 Mount Sinai School Of Medicine Of New York University Herbal remedies for treating allergies and asthma
JP5064630B2 (ja) * 2000-03-09 2012-10-31 エール ユニヴァーシティ 薬草組成物phy906および化学療法におけるその使用
WO2002007743A2 (de) * 2000-07-26 2002-01-31 Vitaplant Ag Piper methysticum pflanzenextrakt

Similar Documents

Publication Publication Date Title
JP2008519767A5 (cg-RX-API-DMAC7.html)
JP2004500390A5 (cg-RX-API-DMAC7.html)
Kim et al. Hepatocellular carcinoma (HCC): beyond sorafenib—chemotherapy
CA2633594C (en) Means and methods for the treatment of tumorous diseases
JP2019503365A5 (cg-RX-API-DMAC7.html)
JP2007529532A5 (cg-RX-API-DMAC7.html)
FI3782612T3 (fi) Sytidiinianalogien oraalisia formulaatioita ja menetelmiä niiden käyttämiseksi
AU2005304493B2 (en) Herbal composition PHY906 and its use in chemotherapy
JP2009515977A5 (cg-RX-API-DMAC7.html)
CN103417561A (zh) 芍药苷类化合物在制备抗肿瘤药物中的用途
JP2010525042A5 (cg-RX-API-DMAC7.html)
JP2023102786A5 (cg-RX-API-DMAC7.html)
JP2015507020A5 (cg-RX-API-DMAC7.html)
WO2009152228A2 (en) Use of the combination of phy906 and a tyrosine kinase inhibitor as a cancer treatment regimen
JP2010528091A5 (cg-RX-API-DMAC7.html)
JP2008536853A5 (cg-RX-API-DMAC7.html)
JP2024016209A5 (cg-RX-API-DMAC7.html)
Bokemeyer et al. A phase II trial of paclitaxel and weekly 24 h infusion of 5-fluorouracil/folinic acid in patients with advanced gastric cancer
RU2008138534A (ru) Фармацевтическая комбинация для лечения и/или хемосенсебилизации опухолей, устойчивых к противораковым средствам
JP2002326936A5 (cg-RX-API-DMAC7.html)
JP2006503095A5 (cg-RX-API-DMAC7.html)
JP2021517886A5 (cg-RX-API-DMAC7.html)
FI4070800T3 (fi) Kladribiinikuuri multippeliskleroosin hoitoa varten
CN108743601A (zh) 一种抗溃疡性结肠炎的黄芩苷-黄芩素组合物及其制剂
JP2007507482A5 (cg-RX-API-DMAC7.html)